These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


297 related items for PubMed ID: 14769809

  • 1. Combined echocardiographic left ventricular hypertrophy and electrocardiographic ST depression improve prediction of mortality in American Indians: the Strong Heart Study.
    Okin PM, Roman MJ, Lee ET, Galloway JM, Howard BV, Devereux RB.
    Hypertension; 2004 Apr; 43(4):769-74. PubMed ID: 14769809
    [Abstract] [Full Text] [Related]

  • 2. Principal component analysis of the T wave and prediction of cardiovascular mortality in American Indians: the Strong Heart Study.
    Okin PM, Devereux RB, Fabsitz RR, Lee ET, Galloway JM, Howard BV.
    Circulation; 2002 Feb 12; 105(6):714-9. PubMed ID: 11839627
    [Abstract] [Full Text] [Related]

  • 3. Computerized ST depression analysis improves prediction of all-cause and cardiovascular mortality: the strong heart study.
    Okin PM, Devereux RB, Kors JA, van Herpen G, Crow RS, Fabsitz RR, Howard BV.
    Ann Noninvasive Electrocardiol; 2001 Apr 12; 6(2):107-16. PubMed ID: 11333167
    [Abstract] [Full Text] [Related]

  • 4. C-reactive protein and electrocardiographic ST-segment depression additively predict mortality: the Strong Heart Study.
    Okin PM, Roman MJ, Best LG, Lee ET, Galloway JM, Howard BV, Devereux RB.
    J Am Coll Cardiol; 2005 Jun 07; 45(11):1787-93. PubMed ID: 15936607
    [Abstract] [Full Text] [Related]

  • 5. Echocardiographic and electrocardiographic diagnoses of left ventricular hypertrophy predict mortality independently of each other in a population of elderly men.
    Sundström J, Lind L, Arnlöv J, Zethelius B, Andrén B, Lithell HO.
    Circulation; 2001 May 15; 103(19):2346-51. PubMed ID: 11352882
    [Abstract] [Full Text] [Related]

  • 6. All-cause and cardiovascular mortality in relation to changing heart rate during treatment of hypertensive patients with electrocardiographic left ventricular hypertrophy.
    Okin PM, Kjeldsen SE, Julius S, Hille DA, Dahlöf B, Edelman JM, Devereux RB.
    Eur Heart J; 2010 Sep 15; 31(18):2271-9. PubMed ID: 20601389
    [Abstract] [Full Text] [Related]

  • 7. Electrocardiographic strain pattern and prediction of cardiovascular morbidity and mortality in hypertensive patients.
    Okin PM, Devereux RB, Nieminen MS, Jern S, Oikarinen L, Viitasalo M, Toivonen L, Kjeldsen SE, Julius S, Snapinn S, Dahlöf B, LIFE Study Investigators.
    Hypertension; 2004 Jul 15; 44(1):48-54. PubMed ID: 15173125
    [Abstract] [Full Text] [Related]

  • 8. Electrocardiographic Left Ventricular Hypertrophy as a Predictor of Cardiovascular Disease Independent of Left Ventricular Anatomy in Subjects Aged ≥65 Years.
    Leigh JA, O'Neal WT, Soliman EZ.
    Am J Cardiol; 2016 Jun 01; 117(11):1831-5. PubMed ID: 27067620
    [Abstract] [Full Text] [Related]

  • 9. Serial evaluation of electrocardiographic left ventricular hypertrophy for prediction of risk in hypertensive patients.
    Okin PM.
    J Electrocardiol; 2009 Jun 01; 42(6):584-8. PubMed ID: 19631946
    [Abstract] [Full Text] [Related]

  • 10. Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events.
    Okin PM, Devereux RB, Jern S, Kjeldsen SE, Julius S, Nieminen MS, Snapinn S, Harris KE, Aurup P, Edelman JM, Wedel H, Lindholm LH, Dahlöf B, LIFE Study Investigators.
    JAMA; 2004 Nov 17; 292(19):2343-9. PubMed ID: 15547161
    [Abstract] [Full Text] [Related]

  • 11. Usefulness of QT-interval parameters for cardiovascular risk stratification in type 2 diabetic patients with arterial hypertension.
    Salles GF, Deccache W, Cardoso CR.
    J Hum Hypertens; 2005 Mar 17; 19(3):241-9. PubMed ID: 15660120
    [Abstract] [Full Text] [Related]

  • 12. Do Combined Electrocardiographic and Echocardiographic Markers of Left Ventricular Hypertrophy Improve Cardiovascular Risk Estimation?
    Cuspidi C, Facchetti R, Sala C, Bombelli M, Tadic M, Grassi G, Mancia G.
    J Clin Hypertens (Greenwich); 2016 Sep 17; 18(9):846-54. PubMed ID: 27160298
    [Abstract] [Full Text] [Related]

  • 13. All-cause mortality and cardiovascular disease mortality in three American Indian populations, aged 45-74 years, 1984-1988. The Strong Heart Study.
    Lee ET, Cowan LD, Welty TK, Sievers M, Howard WJ, Oopik A, Wang W, Yeh J, Devereux RB, Rhoades ER, Fabsitz RR, Go O, Howard BV.
    Am J Epidemiol; 1998 Jun 01; 147(11):995-1008. PubMed ID: 9620042
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Electrocardiographic and Echocardiographic Left Ventricular Hypertrophy in the Prediction of Stroke in the Elderly.
    O'Neal WT, Almahmoud MF, Qureshi WT, Soliman EZ.
    J Stroke Cerebrovasc Dis; 2015 Sep 01; 24(9):1991-7. PubMed ID: 26153509
    [Abstract] [Full Text] [Related]

  • 16. Regression of electrocardiographic left ventricular hypertrophy predicts regression of echocardiographic left ventricular mass: the LIFE study.
    Okin PM, Devereux RB, Liu JE, Oikarinen L, Jern S, Kjeldsen SE, Julius S, Wachtell K, Nieminen MS, Dahlöf B.
    J Hum Hypertens; 2004 Jun 01; 18(6):403-9. PubMed ID: 15057252
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Electrocardiographic Versus Echocardiographic Left Ventricular Hypertrophy in Prediction of Congestive Heart Failure in the Elderly.
    Almahmoud MF, O'Neal WT, Qureshi W, Soliman EZ.
    Clin Cardiol; 2015 Jun 01; 38(6):365-70. PubMed ID: 25962934
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.